Goldenwell Biotech $GWLL Read from its own SEC filings · nothing written, nothing inferred
🫧 Edgar looked up GOLDENWELL BIOTECH, INC. ($GWLL). Last filing: 8-K (4.01 Changes in Registrant's Certifying Accountant), 2026-09-29. 2 event filings (8-K) in the past twelve months. Auditor change (8-K Item 4.01) filed 2026-09-29. Non-reliance (8-K Item 4.02) filed 2026-05-27.
🔖 Exposure: revenue $0K (FY2025). Experience: revenue down 60.4% on the year, down 75.8% a year over 4 years; operating margin -206047.3%, down from -88559.7%. Soundness: equity -951.6% of assets (liabilities exceed assets). Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $0K and $0K next year (method v4.1: its own 2-year record of growth weighed at 25% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $0K to $0K. A statistical range, not company guidance. Against peers (10 filers, $50M+ revenue, food and kindred products): operating margin -206047.3% against a 7.3% median; growth -60.4% against 4.4%.
Cash
| Cash flow (op · inv · fin · free) | −$0M · — · $0M · — |
| Investment book (cash · short · long) | $0M · — · — |
The figures, as filed
| Fiscal year end | 2025-12-31 |
| Revenue | $0M |
| Revenue, on the year | −60.4% |
| Revenue, a year over the record | −75.8% |
| Operating margin | −206047.3% |
| Operating margin, prior year | −88559.7% |
| Net margin | −539038.2% |
| Research and development | not filed separately |
| Total debt | — |
| Equity of assets | −951.6% |
| Return on equity | — |
| Payout of profit | — |
| Dividend per share | — |
| Earnings per share | $0 |
| Book value per share | $-0.00 |
| Revenue per share | $0.00 |
| Shares outstanding | 99,000,000 |
| Audited years read | 5 |
Peers: the median of 10 filers with $50M+ revenue in food and kindred products.
Health HarborGoldenwell Biotech sails as: Rotting at the dock
Health watch · 12 monthsLate annual report noticeEarlier statements no longer to be relied onLate quarterly report noticeAuditor change
Tied up at the dock.
🌊 Visit the Bay →- filed late annual report notice, earlier statements no longer to be relied on, late quarterly report notice, auditor change in the last 12 months
- liabilities exceed assets (often from years of share buybacks, not always distress)
- operating cash flow was negative (-$23K in FY2025)
- revenue is hard to predict: its 80% range is ±90%
Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider. A picture of the signs, not a rating and not investment advice.
- 8-K · 2026-09-29 · 4.01 Changes in Registrant's Certifying Accountant; 9.01 Financial Statements and Exhibits
- 10-Q · 2026-08-14
- 10-Q · 2026-07-01
- 10-K · 2026-07-01
- 8-K · 2026-05-27 · 4.02 Non-Reliance on Previously Issued Financial Statements; 9.01 Financial Statements and Exhibits
- 10-Q · 2025-12-08
Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price. Reporting, not investment advice. No price targets and no trading recommendations. Figures from the SEC’s own data · every filing · this page as JSON · ask about another company